News Detail
New Delhi, 28 Oct 2023: The Drug Controller General of India (DCGI) has added in-vitro diagnostic (IVD) medical devices including those for diagnosis of Covid-19, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) extraction kits, among others into the Class C risk category u......
View Details
Source : Pharmabiz
DCGI
in-vitro diagnostic
IVD medical devices
Covid-19
Ribonucleic acid
RNA
deoxyribonucleic acid
DNA
extraction kits
Class C
Medical Devices Rules
MDR
2017
CDSCO
arterial blood gas
ABG
microcuvette
Related News
- 1900 packings of fake Fair and Glow, Ponds Cream recovered (08-12-2023)
- India plans a digital Drug Regulatory System (08-12-2023)
- First Acute Kidney Injury Diagnostic Test Wins FDA Clearance (08-12-2023)
- Indian pharma companies recorded 9 percent 5-year CAGR (08-12-2023)
- Two crore alcoholic herbal syrup bottles sold across Saurashtra since 2023 (08-12-2023)
- Telangana DCA tightens noose against spurious drug manufacturers following seizure of spurious cancer drugs (08-12-2023)
- US FDA India & DIA India to host series of workshops on generic drug life-cycle management (08-12-2023)
- Gujarat: 8 arrested for manufacture, sale of beer in guise of Ayurvedic syrup (08-12-2023)
- WHO: More contaminated medicinal syrups found in new regions, including Southeast Asia (08-12-2023)
- IPC issues alert for painkiller mefenamic acid (08-12-2023)